AOK Nordost (Brandenburg) writes a discount agreement for blood glucose tests

Conclusion of non-exclusive discount agreements pursuant to section 130a SGB V concerning various active substances / combinations with possible termination at any time under the so-called “open-house procedure”. The earliest start of the contract is 1.5.2017. The term of the contract […]

New diagnostic and therapeutic methods must demonstrate evidence

There is a large difference between the use of the CE mark and the evidence for the reimbursement by German statutory health insurance funds.

DAK (Health Insurance Funds) writes a discount agreement for active substance raltegravir

Substance Raltegravir § 130a Paragraph 8 SGB V (German Law, Sozialgesetzbuch V der Gesetzliche Krankenversicherung) allows health insurance companies and pharmaceutical companies to conclude framework agreements on the medicinal products to be charged to the statutory health insurance funds. The […]

German health care market with growth weaknesses

Germany has the second largest current account surplus in the world. A surplus of current account surplus is generated when Germany exports significantly more than imported and gives more money. In 2015, a new record surplus in the trade balance […]

Online Contact Form